Biochemical markers and prognostic scores for evaluation of prognosis in acute pancreatitis;Estratificación del riesgo: Marcadores bioquímicos y escalas pronósticas en la pancreatitis aguda

Medicina Intensiva

Volumn 27, Issue 2, 2003, Pages 93-100

  Fernandez Castroagudin J ^a   Iglesias Canle, J ^a   Dominguez Munoz J E ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

Acute pancreatitis; Monitoring; Prognosis

Indexed keywords

BIOLOGICAL MARKER; LEUKOCYTE ELASTASE; TRYPSINOGEN ACTIVATION PEPTIDE;

ACUTE PANCREATITIS; CLINICAL EXAMINATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DISEASE SEVERITY; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; MULTIPLE ORGAN FAILURE; PANCREAS NECROSIS; PATIENT MONITORING; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME; REVIEW; SEPSIS;

EID: 0037298343     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(03)79876-3     Document Type: Review

References (72)

1. McMahon MJ, Playforth MJ, Pickford IR. A comparative study of methods for the prediction of severity of attacks of acute pancreatitis. Br J Surg 1980;67:22-5.
2. Corfield AP, Cooper MJ, Williamson RCN, Mayer AD, McMahon MJ, Dickson AP, et al. Prediction of severity in acute pancreatitis: a prospective comparison of three prognostic indices. Lancet 1985;2:403-6.
3. Heath DI, Imrie CW. The diagnosis and assessment of severity in acute pancreatitis. In: Hohnson CD, Imrie CW, editors. Pancreatic disease. Progress and prospect. London: Springer-Verlag, 1991.
4. Uomo G, Manes G, Rabitti PG. Clinical value of multifactorial classification in the prognostic evaluation of acute pancreatitis. In: Malfertheiner P, Domínguez-Muñoz JE, Schulz HU, Lippert H, editors. Diagnostic procedures in pancreatic disease. Berlin-Heidelberg: Springer-Verlag, 1997.
5. Domínguez-Muñoz JE, Carballo F, Garcia MJ, de Diego JM, Campos R, Yanguela J, et al. Evaluation of the clinical usefulness of APACHE II and SAPS systems in the initial prognostic classification of acute pancreatitis: a multicenter study. Pancreas 1993;8: 682-6.
6. Tran DD, Cuesta MA. Evaluation of severity in patients with acute pancreatitis. Am J Gastroenterol 1992;87:604-8.
7. Elebute EA, Stoner HB. The grading of sepsis. Br J Surg 1983;70:29-31.
8. Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982;77:633-8.
9. Ranson JH, Rifkinf KM. Turner JW. Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet 1976;143:209-19.
10. Ranson JHC, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974;139:69-81.
11. Ranson JHC. The timing of biliary surgery in acute pancreatitis. Ann Surg 1979;189:654-62.
12. De Bernardinis M, Violi V, Roncorini L, Boselli AS, Giunta A, Peracchia A. Discriminant power and information content of Ranson's pronostic signs in acute pancreatitis: a metaanalytic study. Crit Care Med 1999;27:2272-83.
13. Demmy TL, Burch JM, Feliciano DV, Mattox KL, Jordan GL. Comparison of multiple-parameter prognostic systems in acute pancreatitis. Am J Surg 1988;156:492-6.
14. Steinberg WM. Predictors of severity of acute pancreatitis. Gastroenterol Clin North Am 1990;19:849-61.
15. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989;2:201-4.
16. Osborne DH, Imrie CW, Carter DC. Bilizry surgery in the same admission for gallstone-associated acute pancreatitis. Br J Surg 1981;68:758-61.
17. Fan ST, Choi TK, Lai ECS, Wong J. Prediction of severity of acute pancreatitis: an alternative approach. Gut 1989;30:1591-5.
18. Williamson RCN. Early assessment of severity in acute pancreatitis. Gut 1984;25:1331-9.
19. Banks PA. Predictors of severity in acute pancreatitis. Pancreas 1991;6(Suppl):7-12.
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE-II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
21. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE-II, clinical assessment and multiple factor scoring systems. Br J Surg 1990;77:1260-4.
22. Banks PA. Acute pancreatitis: medical and surgical management. Am J Gastroenterol 1994;89(Suppl 8):78-85.
23. Brisinda G, Maria G, Ferrante A, Civello IM. Evaluation of prognostic factors in patients with acute pancreatitis. Hepatogastroenterology 1999;46:1990-7.
24. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331-6.
25. London NJ, Neoptolemos JP, Lavelle J, Bailey I, James D. Contrast-enhanced abdominal computed tomography scanning and prediction of severity of acute pancreatitis: a prospective study. Br J Surg 1989;76:878-9.
26. London NJ, Leese T, Lavelle JM, Miles K, West KP, Watkin DF, et al. Rapid-bolus contrast-enhanced dynamic computed tomography in acute pancreatitis: a prospective study. Br J Surg 1991;78:1452-6.
27. Simchuk EJ, Traverso LW, Nukui Y, Kozarek RA. Computed tomography severity index is a predictor of outcomes for severe pancreatitis. Am J Surg 2000;179:352-5.
28. Pitchumoni CS, Agarwal N, Jain NK. Systemic complication of acute pancreatitis. Am J Gastroenterol 1988;83:597-606.
29. Balthazar EJ, Ranson JH, Naidich DP, Megibow AJ, Caccavale R, Cooper MM. Acute pancreatitis: prognostic value of CT. Radiology 1985;156:767-72.
30. Moulton JS. The radiologic assessment of acute pancreatitis and its complications. Pancreas 1991;6(Suppl):13-22.
31. Vesentini S, Bassi C, Talamini G, Campedelli A, Pederzoli P. Positive comparison of C-reactive protein level, Ranson score and contrast-enhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg 1993;-80:755-7.
32. Laccetti M, Rabitti PG, Manes G, Picciotto FP, Esposito P, Uomo G. Relationship between the extent of pancreatic necrosis and sepsis in acute pancreatitis. Eur J Gastroent Hepatol 1993; 5:871-4.
33. Domínguez Muñoz JE, Malfertheiner P. Biochemical markers in the early prognostic evaluation of acute pancreatitis. In: Malfertheiner P, Domínguez-Muñoz JE, Schulz HU, Lippert H, editors. Diagnostic procedures in pancreatic disease. Berlin-Heidelberg: Springer-Verlag, 1997.
34. Ranson JHC, Rifkind KM, Roses DF, Fink SD, Eng K, Localio SA. Objective early identification of severe acute pancreatitis. Am J Gastroenterol 1974;61:443-51.
35. Lankisch PG, Schirren CA, Otto J. Methemalbumin in acute pancreatitis: An evaluation of its prognostic value and comparison with multiple prognostic parameters. Am J Gastroenterol 1989;84:1391-5.
36. Warshaw AL, Lee KH. Serum ribonuclease elevations and pancreatic necrosis in acute pancreatitis. Surgery 1979;86:227-34.
37. Kemmer TP, Malfertheiner P, Büchler M, Kemmer DL, Ditschuneit H. Serum ribonuclease activity in the diagnosis of pancreatic disease. Int J Pancreatol 1991;8:23-33.
38. Heath DI, Wilson C, Gudgeon AM, Jehanli A, Shenkin A, Imrie CW. Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis. Gut 1994;35:1311-5.
39. Gudgeon AM, Heath DI, Hurley P, Jehanli A, Patel G, Wilson C, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990; 335:4-8.
40. Tenner S, Fernández del Castillo C, Warshaw A, Steinberg W, Hermon-Taylor J, Valenzuela JE, et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997;21:105-10.
41. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000;3:1924-5.
42. Rae D, Porter J, Beechey-Newmann N, Sumar N, Bennet D, Hermon-Taylor J. Type 1-phospholipase A2 propeptide in acute lung injury. Lancet 1994;344:1472-3.
43. Pousette Å, Fernstad R, Sköldefors H, Carlström K. A novel assay for pancreatic celular damage: I. Characterization of protein profiles in human pancreatic cytosol and purification and characterization of a pancreatic specific protein. Pancreas 1988;3: 421-6.
44. Schmid SW, Uhl W, Steinle A, Rau B, Seiler C. Büchler MW. Human pancreas-specific protein. A diagnostic and prognostic marker in acute pancreatitis and pancreas transplantation. Int J Pancreatol 1996;19:165-70.
45. Blind PJ, Büchler M, Bläckberg L. Andersson Y, Uhl W, Beger HG, et al. Carboxylic ester hydrolase. A sensitive serum marker and indicator of severity of acute pancreatitis. Int J Pancreatol 1991;8:65-73.
46. Uhl W, Vogel R, Büchler MW. Prognostic evaluation of acute pancreatitis: When and how-Consequences for clinical management. In: Malfertheiner P, Domínguez-Muñoz JE, Schulz HU, Lippert H, editors. Diagnostic procedures in pancreatic disease. Berlin-Heidelberg: Springer-Verlag, 1997.
47. Appelros S, Thim L, Borgstrom A. Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut 1998;42:97-102.
48. Appelros S, Petersson U, Toh S, Johnson C. Borgstrom A. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg 2001;88:216-21.
49. Domínguez-Muñoz JE, Carballo F, Garcfa MJ, Miguel de Diego J, Gea F, Yanguela J, et al. Monitoring of serum proteinase-antiproteinase balance and systemic inflammatory response in the prognostic evaluation of acute pancreatitis: Results of a prospective multicenter study. Dig Dis Sci 1993;38:507-12.
50. 2-macroglobulin and other antiproteinases to the clinical features of acute pancreafitis. Am J Surg 1984;147:164-70.
51. Büchler M, Uhl W, Malfertheiner P. Biochemical staging of acute pancreatitis. In: Beger HG, Büchler M, editors. Acute pancreatitis. Berlin-Heidelberg: Springer-Verlag, 1987.
52. Büchler M, Malfertheiner P, Schötensack C, Uhl W, Beger HG. Sensitivity of antiproteases, complement factors anc C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study. Int J Pancreatol 1986;1:227-35.
53. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989;76:177-81.
54. Lässon A, Ohlsson K. Systemic involvement in pancreatic damage: coagulation and fybrinolysis. Int J Pancreatol 1988;3: 579-86.
55. Hesselvik JF, Blombäck M. Brodin B, Maller R. Coagulation, fibrinolysis and kallikrein systems in sepsis: relation to outcome. Crit Care Med 1989;17:724-33.
56. Lässon A, Ohlsson K. Changes in the kallikrein-kinin system during acute pancreatitis in man. Thrombos Res 1984;35:27-41.
57. Domínguez-Muñoz JE, Viedma JA, Pérez -Mateo M, Carballo F, García Fe M. Inflammatory response in the initial phase of acute pancreatitis: relationship to the onset and severity of the disease. Rev Esp Enferm Dig 1995;87:225-46.
58. Domínguez-Muñoz JE, Carballo F, García MJ, De Diego JM, Rábago, Simon MA, et al. Clinical usefulness of polymorphonuclear elastase in prediction of severity of acute pancreatitis: Results of a multicentre study. Br J Surg 1991;78:1230-4.
59. 2-macroglobulin. Dig Dis Sci 1990;35:97-105.
60. Liras G, Carballo F, Domínguez-Muñoz JE, De la Morena J. Clinical value of an automated granulocyte elastase assay in predicting severity of acute pancreatitis. Rev Esp Enferm Dig 1995;87; 641-52.
61. Viedma JA. Pérez-Mateo M, Domínguez-Muñoz JE, Carballo F. Role of interleukin-6 in acute pancreatitis: Comparison with C-reactive protein and phospholipase A. Gut 1992;33:1264-7.
62. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-5.
63. Heath DJ, Crickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute-phase response and potential as an early means of severity assesement in acute pancreatitis. Gut 1993;34:41-5.
64. Chen CC, Wang SS, Lee FY, Chang FY, Lee SD. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999;94:213-8.
65. Ikei S, Ogawa M, Yamaguchi Y. Blood concentration of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the ocurrence of multiple organ failures at the early stage of acute pancreatitis. J Gastroenterol Hepatol 1998;13: 1274-83.
66. 2 in human acute pancreatitis. Gastroenterology 1989;97:1521-6.
67. 2 activity in acute pancreatitis: an early guide to severity. Br J Surg 1989;76:731-2.
68. Uhl W, Büchler M, Malfertheiner P, Martini M, Beger HG. PMN-Elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991;6:253-9.
69. Mayer AD, McMahon MJ, Bowen M, Cooper EH. C-reactive protein: an aid to assessment and monitoring acute pancreatitis. J Clin Pathol 1984;37 207-11.
70. Kilanpaa-Back ML, Takala A, Kemppainen EA, Puolakkainen PA, Leppaniemi AK, Karonen SL, et al. Procalcitonin. soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001;29: 63-9.
71. Mandi Y, Farkas G, Takacs T, Boda K, Lonovics J. Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis. Int J Pancreatol 2000;28:41-9.
72. Domínguez-Muñoz JE, Malfertheiner P. Management of severe acute pancreatitis. Gastroenterologist 1993;1:248-56.